| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd. | President and CEO, Director | Ordinary Shares | 375K | $581K | $1.55 | Oct 19, 2023 | Direct |
| Aquestive Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $4.88 | Apr 1, 2024 | Direct |
| Gamida Cell Ltd. | President and CEO, Director | Employee Share Option (Right to Buy) | 218K | Oct 19, 2023 | Direct | ||
| Aquestive Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 57K | May 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | May 10, 2024 | 1 | $0 | 4 | May 13, 2024 | Director |
| AQST | Aquestive Therapeutics, Inc. | Apr 1, 2024 | 0 | $0 | 3 | Apr 26, 2024 | Director |
| GMDA | Gamida Cell Ltd. | Oct 19, 2023 | 2 | $0 | 4 | Oct 20, 2023 | President and CEO, Director |
| GMDA | Gamida Cell Ltd. | Oct 19, 2023 | 2 | $0 | 4/A | Oct 20, 2023 | President and CEO, Director |
| GMDA | Gamida Cell Ltd. | Sep 30, 2022 | 1 | $25K | 4 | Oct 4, 2022 | President and CEO, Director |
| GMDA | Gamida Cell Ltd. | Sep 19, 2022 | 2 | $0 | 4 | Sep 20, 2022 | President and CEO, Director |
| GMDA | Gamida Cell Ltd. | Sep 19, 2022 | 0 | $0 | 3 | Sep 20, 2022 | President and CEO, Director |